VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $610 | -7.2% | 24,850 | -12.0% | 0.05% | -10.5% |
Q1 2023 | $657 | -9.1% | 28,250 | -1.1% | 0.06% | -13.6% |
Q4 2022 | $723 | -99.9% | 28,550 | -15.2% | 0.07% | +3.1% |
Q3 2022 | $649,000 | -27.5% | 33,650 | -4.3% | 0.06% | -22.0% |
Q2 2022 | $895,000 | -6.6% | 35,150 | -5.6% | 0.08% | +9.3% |
Q1 2022 | $958,000 | -40.6% | 37,250 | -3.4% | 0.08% | -40.0% |
Q4 2021 | $1,614,000 | -3.8% | 38,550 | 0.0% | 0.12% | -11.3% |
Q3 2021 | $1,678,000 | -12.5% | 38,550 | -4.9% | 0.14% | -7.8% |
Q2 2021 | $1,917,000 | -9.8% | 40,550 | -2.2% | 0.15% | -16.4% |
Q1 2021 | $2,125,000 | +246.7% | 41,450 | +81.0% | 0.18% | +210.2% |
Q4 2020 | $613,000 | +40.0% | 22,900 | +79.6% | 0.06% | +22.9% |
Q3 2020 | $438,000 | – | 12,750 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |